JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $766,000 | -65.7% | 100,000 | 0.0% | 0.01% | -68.4% |
| Q1 2018 | $2,235,000 | +75.3% | 100,000 | 0.0% | 0.02% | +72.7% |
| Q4 2017 | $1,275,000 | -18.2% | 100,000 | 0.0% | 0.01% | -15.4% |
| Q3 2017 | $1,558,000 | +11.0% | 100,000 | 0.0% | 0.01% | +8.3% |
| Q2 2017 | $1,403,000 | -36.2% | 100,000 | 0.0% | 0.01% | -33.3% |
| Q1 2017 | $2,199,000 | – | 100,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |